From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Tom Winnifrith Bearcast: The next Prime Minister gives a kiss of death to Ceres Power

By Tom Winnifrith | Friday 24 March 2023


Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


Tomorrow is my third training walk for Rogue Bloggers for Woodlarks. I am targeting 11 miles and will post a picture of the service station on the Wrexham roundabout which is my turnaround point if we can get donations well above £1,000 before I leave. I can't say fairer than that, please donate HERE. In today's podcast I discuss Deutsche Bank ( the next Credit Suisse?), the fraud Supply@ME Capital (SYME), nanosynth (NNN), Kefi Gold & Copper (KEFI), Ceres Power (CWR), Genflow Biosciences (GENF) and Celadon Pharmaceuticals (CEL) and lock in expiries in a thin market.
You must be a paid subscriber to listen to Bearcast
ShareProphets is reader-supported journalism

Join us for free and gain access to three articles per month

Or become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 09:17:00